Symbols

MMED

MiniMed Group·NASDAQ

--(--)

Is MMED fundamentally strong?

MMED scores 0.00/10 on fundamentals and holds a Fair valuation at present. Backed by its -0.84% ROE, -6.79% net margin, -24.61 P/E ratio, 1.46 P/B ratio, and 0.00% earnings growth, these metrics solidify its Neutral investment rating.